Back to KERX Stock Lookup
Pages: 1 2 »» Last Page

Keryx Biopharma (KERX) – Press Releases

Jun 27, 2016 08:00 AM Douglas Jermasek to Join Keryx Biopharmaceuticals as Vice President, Marketing and Strategy
Jun 23, 2016 08:00 AM Momenta Pharmaceuticals Appoints Steven C. Gilman, Ph.D. to Board of Directors
Jun 21, 2016 08:00 AM Keryx Biopharmaceuticals Appoints Two New Board Members
Jun 14, 2016 08:30 AM Keryx Biopharmaceuticals to Present at JMP’s Life Science Conference on Tuesday, June 21
Apr 28, 2016 07:00 AM Keryx Biopharmaceuticals Announces First Quarter 2016 Financial Results
Apr 14, 2016 08:30 AM Keryx Biopharmaceuticals to Host Conference Call of First Quarter 2016 Financial Results on Thursday, April 28, 2016
Apr 1, 2016 08:30 AM Keryx Biopharmaceuticals Announces New Appointments and Changes to its Board of Directors
Mar 29, 2016 06:30 AM Keryx Biopharmaceuticals Announces Positive Top-line Results from Pivotal  Phase 3 Study of Ferric Citrate for the Treatment of Iron Deficiency Anemia  in Adults with Non-Dialysis Dependent Chronic
Mar 1, 2016 08:30 AM Keryx Biopharmaceuticals to Present at Cowen and Company’s 36th Annual Health Care Conference on Monday, March 7
Feb 25, 2016 07:00 AM Keryx Biopharmaceuticals Announces Fourth Quarter and Year-End 2015 Financial Results
Feb 11, 2016 08:00 AM Keryx Biopharmaceuticals to Host Conference Call on Fourth Quarter and Year End 2015 Financial Results on Thursday, February 25, 2016
Dec 22, 2015 04:05 PM Keryx Biopharmaceuticals to Present at the 34th Annual J.P. Morgan Healthcare Conference on Monday, January 11
Dec 10, 2015 08:00 AM Keryx Announces Appointment of John P. Butler to its Board of Directors
Dec 1, 2015 09:05 AM Keryx Biopharmaceuticals Announces Webcast of Presentation at Oppenheimer's 26th Annual Healthcare Conference
Nov 3, 2015 04:05 PM Keryx Biopharmaceuticals Announces Participation at Two Upcoming Investor Conferences
Oct 29, 2015 07:00 AM Keryx Biopharmaceuticals Announces Third Quarter 2015 Financial Results
Oct 21, 2015 09:05 AM Keryx Biopharmaceuticals to Host Conference Call of Third Quarter 2015 Financial Results on Thursday, October 29, 2015
Oct 15, 2015 07:00 AM Keryx Biopharmaceuticals Announces $125 Million Private Placement of Convertible Senior Notes With The Baupost Group, L.L.C.
Sep 24, 2015 07:00 AM Keryx Receives European Approval for Fexeric(R) (ferric citrate coordination complex) for the Treatment of Hyperphosphatemia in Adults With Chronic Kidney Disease
Sep 24, 2015 07:00 AM Keryx Receives European Approval for Fexeric(R) (ferric citrate coordination complex) for the Treatment of Hyperphosphatemia in Adults With Chronic Kidney Disease
Sep 9, 2015 08:30 AM Keryx Biopharmaceuticals Announces Participation at Upcoming Investor Conferences
Aug 5, 2015 07:00 AM Keryx Biopharmaceuticals Announces Second Quarter 2015 Financial Results
Aug 5, 2015 07:00 AM Keryx Biopharmaceuticals Announces Second Quarter 2015 Financial Results
Jul 28, 2015 04:05 PM Keryx Biopharmaceuticals to Host Conference Call of Second Quarter 2015 Financial Results on Wednesday, August 5, 2015
Jul 28, 2015 04:05 PM Keryx Biopharmaceuticals to Host Conference Call of Second Quarter 2015 Financial Results on Wednesday, August 5, 2015
Jul 27, 2015 08:00 AM Keryx Biopharmaceuticals Appoints Scott A. Holmes as Chief Financial Officer
Jul 24, 2015 07:10 AM Keryx Receives CHMP Positive Opinion for Fexeric(R) (Ferric Citrate Coordination Complex) for the Treatment of Hyperphosphatemia in Adults With Chronic Kidney Disease
Jul 24, 2015 07:10 AM Keryx Receives CHMP Positive Opinion for Fexeric(R) (Ferric Citrate Coordination Complex) for the Treatment of Hyperphosphatemia in Adults With Chronic Kidney Disease
Jun 24, 2015 08:00 AM Keryx Announces Two National Insurance Providers Added Auryxia(TM) to Their Medicare Part D Formularies
Jun 16, 2015 09:00 AM Keryx Biopharmaceuticals to Present at the JMP Securities Life Sciences Conference 2015
May 12, 2015 06:32 PM CORRECTING and REPLACING -- Keryx Biopharmaceuticals to Present at Bank of America Merrill Lynch 2015 Health Care Conference
May 12, 2015 06:32 PM CORRECTING and REPLACING -- Keryx Biopharmaceuticals to Present at Bank of America Merrill Lynch 2015 Health Care Conference
May 5, 2015 04:30 PM Keryx Biopharmaceuticals to Present at Bank of America Merrill Lynch 2015 Health Care Conference
May 5, 2015 04:30 PM Keryx Biopharmaceuticals to Present at Bank of America Merrill Lynch 2015 Health Care Conference
May 4, 2015 07:15 AM Keryx Biopharmaceuticals Announces First Quarter 2015 Financial Results
May 4, 2015 07:15 AM Keryx Biopharmaceuticals Announces First Quarter 2015 Financial Results
Apr 30, 2015 04:30 PM Keryx Biopharmaceuticals Completes Transition of CEO Role to Greg Madison
Apr 30, 2015 04:30 PM Keryx Biopharmaceuticals Completes Transition of CEO Role to Greg Madison
Apr 27, 2015 04:30 PM Keryx Biopharmaceuticals, Inc. to Host Conference Call on First Quarter 2015 Financial Results
Apr 27, 2015 04:30 PM Keryx Biopharmaceuticals, Inc. to Host Conference Call on First Quarter 2015 Financial Results
Apr 23, 2015 08:00 AM Keryx Biopharmaceuticals Appoints John F. Neylan, MD, as Chief Medical Officer
Mar 18, 2015 04:15 PM Dyadic International Announces The Appointment Of Jack Kaye To Its Board of Directors
Mar 10, 2015 04:55 PM Keryx Biopharmaceuticals Announces Appointment of Greg Madison to Its Board of Directors
Mar 10, 2015 04:55 PM Keryx Biopharmaceuticals Announces Appointment of Greg Madison to Its Board of Directors
Mar 4, 2015 07:45 AM Keryx Biopharmaceuticals Announces Publication of Auryxia(TM) (ferric citrate) Analysis in Journal of the American Society of Nephrology
Feb 25, 2015 04:10 PM Keryx Biopharmaceuticals Announces Participation at Upcoming Investor Conferences
Feb 18, 2015 08:00 AM Keryx Biopharmaceuticals, Inc. to Host Conference Call on Fourth Quarter and Year End 2014 Financial Results
Jan 21, 2015 07:53 PM Keryx Biopharmaceuticals, Inc. Announces Pricing of $110 Million Public Offering of Common Stock
Jan 20, 2015 04:05 PM Keryx Biopharmaceuticals, Inc. Announces $100 Million Proposed Public Offering of Common Stock
Jan 11, 2015 10:00 PM Keryx Biopharmaceuticals Announces Transition of Leadership
Pages: 1 2 »» Last Page

Back to KERX Stock Lookup